<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02887664</url>
  </required_header>
  <id_info>
    <org_study_id>0285-16-TLV-DM</org_study_id>
    <nct_id>NCT02887664</nct_id>
  </id_info>
  <brief_title>The Correlation Between the n-6:n-3 Ratio and Inflammatory Markers in Small for Gestational Age (SGA) Infants Compared With Appropriate for Gestational Age (AGA) Infants</brief_title>
  <official_title>The Correlation Between the n-6:n-3 Ratio and Inflammatory Markers in Small for Gestational Age (SGA) Infants Compared With Appropriate for Gestational Age (AGA) Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Numerous studies have recommended the use of n-3 PUFA supplementation during human pregnancy
      and lactation for the prevention of preterm birth, beneficial effects on fetal development,
      visual and cognitive development and other functional outcomes of the infants.

      The aim of the present study is to assess the correlation between ratio of n-3:n-6 fatty acid
      and inflammation markers in SGA infants compared with appropriate for gestational age (AGA)
      infants. The investigators hypothesize that in SGA infants n-3 and n-6 fatty acid
      concentrations in cord blood will differ from those observed in AGA and might correlate with
      the level of circulating mediators.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2018</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cord blood analysis</measure>
    <time_frame>at time of delivery</time_frame>
    <description>Determination of the cord blood values of inflammatory markers (CRP, IL-6, TPO, TNF-alpha) and of the n-6:n-3 ratio</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maternal blood analysis</measure>
    <time_frame>at time of delivery</time_frame>
    <description>Determination of the maternal blood values of inflammatory markers (CRP, IL-6, TPO, TNF-alpha) and of n-6:n-3 ratio</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Small for Gestational Age Infants</condition>
  <condition>Appropriate for Gestational Age Infants</condition>
  <arm_group>
    <arm_group_label>Blood test in Mothers of SGA Infants</arm_group_label>
    <description>In mothers of Small for Gestational Age (SGA) Infants, maternal and cord blood test will be performed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blood test in Mothers of AGA infants</arm_group_label>
    <description>In mothers of Appropriate for Gestational Age (AGA) Infants, maternal and cord blood test will be performed</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood test</intervention_name>
    <description>Blood will be drawn from mother's vein and from the cord to test for n-6:n-3 ratio and inflammatory markers: CRP, IL-6, TPO and TNF-alpha markers</description>
    <arm_group_label>Blood test in Mothers of SGA Infants</arm_group_label>
    <arm_group_label>Blood test in Mothers of AGA infants</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Mothers of term or or near term infants after delivery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mothers of SGA infants ( above 35 week of gestation)

          -  Mothers of term and near-term AGA infants

        Exclusion Criteria:

          -  Maternal chronic diseases, smoking, diabetes, alcohol use, pregnancy-associated
             hypertension and pre-eclampsia

          -  Neonatal depression

          -  Congenital malformations

          -  Intrauterine infections

          -  Chromosomal aberrations

          -  Mothers interested in cord blood banking
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dror Mandel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neonatology, Lis Maternity Hospital, Tel Aviv Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dror Mandel, MD</last_name>
    <phone>+97236925690</phone>
    <email>drorm@tlvmc.gov.il</email>
  </overall_contact>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 22, 2016</study_first_submitted>
  <study_first_submitted_qc>August 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 2, 2016</study_first_posted>
  <last_update_submitted>April 10, 2018</last_update_submitted>
  <last_update_submitted_qc>April 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

